Changes in the calibre of the upper airway and the surrounding structures after maxillomandibular advancement for obstructive sleep apnoea

https://doi.org/10.1016/j.bjoms.2014.02.006Get rights and content

Abstract

Maxillomandibular advancement (MMA) is effective in the treatment of obstructive sleep apnoea. We aimed to assess changes in the calibre of the upper airway, facial skeleton, and surrounding structural position after MMA and their association with improvement in symptoms. Sixteen consecutive adults with moderate-to-severe apnoea were treated by primary MMA. Polysomnography and computed tomography (CT) of the head and neck were done before and at least 6 months after MMA. The calibre of the upper airway, the facial skeleton, and the surrounding structures were measured with image analysis software. After MMA, patients had a significant reduction in their apnoea-hypopnoea index (31.2 (18.8) number of events (n)/hour (h)). The mean (SD) volume of the airway increased significantly in the velopharynx (p < 0.01), oropharynx (p = 0.001), and hypopharynx (p < 0.001) (by 2.3 (2.4), 2.1 (2.6), and 1.7 (1.1) cm3, respectively) and the length of the airway was significantly decreased (by 3.1 (3.5) mm p < 0.01). The soft palate (p < 0.001), tongue (p < 0.001), and hyoid (p = 0.001) moved significantly anteriorly (by 4.4 (2.0), 7.5 (2.8), and 5.7 (5.0) mm, respectively), and these movements were related to the MMA (r = 0.6–0.8). The improvement in the apnoea-hypopnoea index was associated with both maxillary advancement and anterior movements of the soft palate and hyoid (r = 0.6–0.7). The results of this study suggest that MMA increases the volume in the upper airway and reduces its length. Improvement in obstructive sleep apnoea is associated with the extent of the anterior movements of the maxilla, soft palate, and hyoid.

Introduction

Maxillomandibular advancement (MMA) is used in the treatment of obstructive sleep apnoea as an effective alternative to continuous positive airway pressure (CPAP).1 While CPAP remains the gold standard because it is highly efficacious, other options are needed because the clinical effectiveness of CPAP is often limited because patients find it difficult to tolerate.2 MMA advances the maxilla and mandible to increase the calibre of the upper airway, thereby preventing its collapse during sleep. However, the mechanisms by which MMA improves sleep apnoea are not well understood.

Although MMA has been shown to improve the calibre of the upper airway,3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 these studies predominantly used cephalometric radiographs for assessment. Such measurements have the disadvantage that the images are usually taken with the patient upright (not a natural sleeping position), and a lateral cephalometric view of the airway limits its 3-dimensional form by not capturing the width of the airway. The surrounding structures (soft palate, tongue, and hyoid), the interaction between the upper airway and the surrounding structures, and the response to treatment, have never been systematically studied to our knowledge in patients treated by MMA.

Computed tomography (CT) is probably one of the best methods for assessment of the 3-dimensional structures of the upper airway, facial skeleton, and surroundings. In this study we aimed to evaluate the mechanism that underlies MMA in patients with obstructive sleep apnoea, and we used CT to assess the effects on the calibre of the upper airway and on the surrounding structures when the patient was awake.

Section snippets

Patients

We prospectively recruited adult patients with obstructive sleep apnoea from the Sleep Centre for primary treatment with MMA. Patients were included if they had at least 2 symptoms of sleep apnoea (snoring, witnessed apnoeas, fragmented sleep, or daytime sleepiness) and they had moderate-to-severe obstructive sleep apnoea on nocturnal polysomnography (apnoea-hypopnoea index (AHI)  15 n/h).15, 16 Patients were excluded if they had cleft palate, genetic syndromes, or were unable to comply with the

Results

The sample comprised 16 patients, 12 men and 4 women, mean (SD) age 33 (7.9) years (range 22–48) and mean (SD) body mass index (BMI) 22 (3.3) (range 17–28). All but one patient had skeletal Class II deformities. The mean duration of follow-up was 12 (8) months. Although most patients lost some weight postoperatively, their BMI had returned to baseline by the time of postoperative polysomnography (p = 0.4).

Discussion

We have challenged the traditional thinking that the primary mechanism of MMA is to increase the anteroposterior dimensions of the velopharynx and oropharynx by advancing the soft palate and tongue, thereby preventing collapse of the upper airway during sleep. One key finding was that MMA improves the calibre of the upper airway, as a result of increased volumes in the velopharynx, oropharynx, and hypopharynx and is mediated by increases in their anteroposterior and lateral dimensions. These

Acknowledgement

This study was supported by Chang Gung Memorial Hospital, Taiwan (CMRP390742).

References (25)

  • R.W. Riley et al.

    Maxillofacial surgery and obstructive sleep apnea: a review of 80 patients

    Otolaryngol Head Neck Surg

    (1989)
  • P.D. Waite et al.

    Maxillomandibular advancement surgery in 23 patients with obstructive sleep apnea syndrome

    J Oral Maxillofac Surg

    (1989)
  • Cited by (47)

    • Surgical Correction of Maxillofacial Skeletal Deformities

      2023, Journal of Oral and Maxillofacial Surgery
    • Upper airways after mandibular advancement orthognathic surgery: A 4-year follow-up

      2021, American Journal of Orthodontics and Dentofacial Orthopedics
    • Maxillomandibular advancement versus multilevel surgery for treatment of obstructive sleep apnea: A systematic review and meta-analysis

      2021, Sleep Medicine Reviews
      Citation Excerpt :

      The observed superiority of MMA over MLS in treating OSA is explained by enlargement of the entire retropalatal and retrolingual airway by expanding the skeletal framework, while MLS cannot. Currently, there are a few studies [25,31,40] reporting the significant increases in pharyngeal airway volume (PAV) in OSA patients treated with MMA, by 60.5%, 35.7% and 35.4%, respectively. However, to our knowledge, only Chiffer et al. [54] quantitatively measured the volumetric changes in upper airway before and after MLS for treating OSA.

    View all citing articles on Scopus
    View full text